{"SPADE_UN_19653": {"Sequence Information": {"Peptide Name": "Pumilarin (46-70)[G2W,T5K,Q8K,Y9K,G18W], Syn-Safencin-P96", "Sequence": "AWKEKIRKKLKNEIKKKWRKAVIAW", "Sequence Length": 25, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Insecticidal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "6O8T", "UniProt Entry": [{"uniprotId": "P0DTW2", "uniprotUrl": "http://www.uniprot.org/uniprot/P0DTW2", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}, {"uniprotId": "A0A1L6ZNG9", "uniprotUrl": "http://www.uniprot.org/uniprot/A0A1L6ZNG9", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.", "Pubmed ID": "29463889", "Reference": "J Antibiot (Tokyo). 2018;:", "Author": "Fields FR, Carothers KE, Balsara RD, Ploplis VA, Castellino FJ, Lee SW", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29463889"}, {"Title": "Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.", "Pubmed ID": "32566907", "Reference": "ACS Pharmacol Transl Sci. 2020;3:418-424", "Author": "Fields FR, et al.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32566907"}], "Mass": 3179.89, "PI": 10.84, "Net Charge": 9, "Hydrophobicity": -1.22, "Frequent Amino Acids": "KAI", "Absent Amino Acids": "CDFGHMOPQSTUY", "Basic Residues": 11, "Acidic Residues": 2, "Hydrophobic Residues": 8, "Polar Residues": 17, "Positive Residues": 11, "Negative Residues": 2, "SPADE ID": "SPADE_UN_19653", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_19653", "Similarity": 1.0, "Sequence": "AWKEKIRKKLKNEIKKKWRKAVIAW"}, {"SPADE_ID": "SPADE_UN_23080", "Similarity": 0.96, "Sequence": "AWKEKIRKKLKNEIKKKGRKAVIAW"}, {"SPADE_ID": "SPADE_UN_23081", "Similarity": 0.96, "Sequence": "AGKEKIRKKLKNEIKKKWRKAVIAW"}], "Hemolytic Activity": "Human keratinocytes HaCat:25% Cytotoxicity=10 µM,Sheep erythrocytes:20% Hemolysis=10 µM,Human keratinocytes HaCat:15% Cytotoxicity=64 µg/ml,Sheep erythrocytes:<5% Hemolysis=128 µg/ml", "Target Organism": "Escherichia coli BL21(MIC=2µM),Xanthomonas axonopodis pv. phaseoli ATCC 9563(MIC=0.25µM),Pseudomonas aeruginosa PAO1(MIC=8µM),Streptococcus pyogenes GAS M1T1(MIC=8µM),Pseudomonas syringae(MIC=>=8µM),Staphylococcus aureus(0-10% Inhibition=8µM),Klebsiella pneumoniae NCTC 13368(MIC=16µg/ml),Klebsiella pneumoniae M6(MIC=8µg/ml),Acinetobacter baumannii AYE(MIC=1µg/ml),Acinetobacter baumannii ATCC 17987(MIC=1µg/ml),Pseudomonas aeruginosa PAO1(MIC=16µg/ml),Pseudomonas aeruginosa NCTC 13437(MIC=128µg/ml),Escherichia coli NCTC 12923(MIC=0.5µg/ml),Xanthomonas axonopodis pv. phaseoli(MIC=0.25µg/ml),Pseudomonas syringae pv. tomato(MIC=0.25µg/ml),Enterococcus faecalis NCTC 12204(MIC=16µg/ml),Enterococcus faecalis NCTC 12201(MIC=128µg/ml),Enterococcus faecalis NCTC 775(MIC=>128µg/ml),Staphylococcus aureus 15(MIC=>=128µg/ml),Staphylococcus aureus NCTC 9144(MIC=8µg/ml),Escherichia coli 319238(MIC=4µg/ml),Escherichia coli LEC 001(MIC=8µg/ml),Escherichia coli CFI_161_NDM(MIC=1µg/ml),Escherichia coli CFI_160_KPC2(MIC=2µg/ml),Acinetobacter baylyi ADP1(MIC=2µg/ml),Acinetobacter baumannii NCTC 13302(MIC=1µg/ml),Acinetobacter baumannii NCTC 13424(MIC=2µg/ml),Acinetobacter baumannii(MIC=1µg/ml),Galleria mellonella(no activity data)"}}}